| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 03/25/2004 | WO2004025267A2 Method for testing drug susceptibility of hiv |
| 03/25/2004 | WO2004025256A2 Viral deconstruction through capsid assembly in vitro |
| 03/25/2004 | WO2004024915A1 Gene expression system based on codon translation efficiency |
| 03/25/2004 | WO2004024905A1 Recombinant human herpes simplex virus for producing lentivirus vectors |
| 03/25/2004 | WO2004024904A2 Infectious hepacivirus pseudo-particles containing functional e1, e2 envelope proteins |
| 03/25/2004 | WO2004024867A2 Vigilant vector system |
| 03/25/2004 | WO2003091401A3 Multi plasmid system for the production of influenza virus |
| 03/25/2004 | WO2003087330A3 Vac-bac shuttle vector system |
| 03/25/2004 | WO2003076591A3 Compositions and methods for generating an immune response |
| 03/25/2004 | WO2003060088A3 Viral vaccine production method |
| 03/25/2004 | WO2003056023A8 Double-stranded cyclic dna capable of proliferating as artificial e. coli chromosome |
| 03/25/2004 | WO2002059321A3 Hepatitis c virus replicons and replicon enhanced cells |
| 03/25/2004 | US20040058439 High titer recombinant AAV production |
| 03/25/2004 | US20040058414 Preparing antibody capable of binding and inhibiting activity of interleukin-2 and receptor, herpes viral epitopes and interferon receptors; diagnosis and treatment of viral and autoimmune diseases |
| 03/25/2004 | US20040057967 Generation of virus-like particles and demonstration of lipid rafts as sites of filovirus entry and budding |
| 03/25/2004 | US20040057930 Method for the development of an HIV vaccine |
| 03/25/2004 | US20040057929 Administering viruses selected from modified adenovirus, modified HSV, modified vaccinia virus and modified parapoxvirus to mammal having Ras-activated pathway to result in lysis of proliferating cells |
| 03/25/2004 | CA2498776A1 Gene expression system based on codon translation efficiency |
| 03/25/2004 | CA2498770A1 Infectious hepacivirus pseudo-particles containing functional e1, e2 envelope proteins |
| 03/25/2004 | CA2498367A1 Viral deconstruction through capsid assembly in vitro |
| 03/24/2004 | EP1399574A2 Improved vectors for gene therapy |
| 03/24/2004 | EP1399551A2 Method for separating bacterial cells and cell components |
| 03/24/2004 | EP1399183A2 Chimeric alphavirus replicon particles |
| 03/24/2004 | CN1483818A Method for extracting SARS vivus sample |
| 03/23/2004 | US6710173 Nucleic acid encoding modified viral env gene of hiv-1 isolate, comprising nucleotide segment encoding modified gp120 and gp41 complex, forming stabilizing disulfide bond between gp120 and gp41, enhancing binding to neutralizing antibodies |
| 03/19/2004 | CA2440914A1 Process for sterilization of protein containing biological compositions |
| 03/18/2004 | WO2004022762A1 Orthopoxvirus vectors, genes and products thereof |
| 03/18/2004 | WO2004022761A1 Retroviral vector and stable packaging cell lines |
| 03/18/2004 | WO2004022740A1 Satellite rnas and method of controlling cucumber mosaic virus using the same |
| 03/18/2004 | WO2004022729A1 Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions |
| 03/18/2004 | WO2004022726A1 Method of controlling biotic function through mechanical vibration and device therefor |
| 03/18/2004 | WO2004022722A2 Lentiviral vectors, related reagents, and methods of use thereof |
| 03/18/2004 | WO2004022716A2 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 03/18/2004 | WO2004022585A1 Hbv precore protein capable of forming particles |
| 03/18/2004 | WO2004021781A2 Cryptophlebia leucotreta granulovirus (crlegv-sa) as a biological control agent |
| 03/18/2004 | WO2003040305A3 Porcine adenovirus e1 and e4 regions |
| 03/18/2004 | WO2003022202A3 Compositions and methods for treatment of cancer |
| 03/18/2004 | US20040055036 Toxin genes from the bacteria xenorhabdus nematophilus and photorhabdus luminescens |
| 03/18/2004 | US20040053316 Contacting composition with an aziridine derivative inactivating agent; killed virus-containing vaccines |
| 03/18/2004 | US20040053228 Apoptosis inhibitory polypeptides, gene and polynucleotide encoding it and compositions containing the same |
| 03/18/2004 | US20040053208 Methods to selectively inactivate parasites in biological compositions |
| 03/18/2004 | US20040052818 Flavivirus mutant has a deletion in the capsid protein of at least more than 4 successive amino acids, wherein the carboxy terminal hydrophobic region is not affected by the deletion |
| 03/18/2004 | US20040052775 Antigens; induce immunology response; prevent infections; genetic engineering |
| 03/18/2004 | US20040052764 Recombinant aav vectors with aav5 capsids and aav5 vectors pseudotyped in heterologous capsids |
| 03/18/2004 | CA2498297A1 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 03/18/2004 | CA2497972A1 Hbv precore protein having a particle-forming ability |
| 03/18/2004 | CA2497750A1 Orthopoxvirus vectors, genes and products thereof |
| 03/17/2004 | EP1398371A1 Infectious HCV pseudo-particles containing functional E1, E2 envelope proteins |
| 03/17/2004 | EP1397499A2 Aav helper plasmids for helper virus-free packaging and pseudo typification of aav vectors |
| 03/17/2004 | EP1397498A1 Delections in arterivirus replicons |
| 03/17/2004 | EP0973546B1 Stabilized human papillomavirus formulations |
| 03/17/2004 | EP0573611B1 Improved epitode displaying phage |
| 03/17/2004 | CN1482239A Human recombinant herpes simplex virus for producing slow virus vector |
| 03/17/2004 | CN1142276C Pronucleus enhancer sample sequence and its application |
| 03/17/2004 | CN1142272C Use of recombined adenovirus carrying hepatocyte growth factor gene |
| 03/17/2004 | CN1142271C Toxicity attenuated Japanese encephalitis virus adapted to vero cell and vaccine thereof |
| 03/16/2004 | US6706874 Viral nucleotide sequences for use in the prevention and treatment of viral diseases |
| 03/16/2004 | US6706873 Nucleic acid molecule encoding specified amino acid sequence |
| 03/16/2004 | US6706523 Nucleoprotein is mutated at the amino acid wherein phosphorylation occurs |
| 03/16/2004 | US6706515 EHV-1 vectors |
| 03/16/2004 | US6706501 Isolated nucleic acid molecule comprising selected nucleic acid sequence, encoding protein having 10,12-linoleate isomerase activity |
| 03/11/2004 | WO2004020971A2 Chromatographic methods for adenovirus purification |
| 03/11/2004 | WO2004020644A1 Non-human herpesviruses as vectors |
| 03/11/2004 | WO2004020635A1 Bacteriophages and remedies for bacterial infection |
| 03/11/2004 | WO2004020615A1 Method for the production of virus-analog particles for packing biologically active macromolecule by in vitro assembly of capsomers to which the macromolecules are bound |
| 03/11/2004 | WO2004020600A2 Modified aav |
| 03/11/2004 | WO2004007537A3 Modified adenoviral fiber with ablated to cellular receptors |
| 03/11/2004 | WO2003068933A3 Optimization of gene sequences of virus-like particles for expression in insect cells |
| 03/11/2004 | WO2003049767A3 Method of large scale production of hepatitis a virus |
| 03/11/2004 | WO2003026479A3 Methods of suppressing microglial activation |
| 03/11/2004 | WO2002072802A3 Live attenuated strains of prrs virus |
| 03/11/2004 | US20040049014 Production of non-immunogenic antibodies having strong affinity for a predetermined antigen |
| 03/11/2004 | US20040048338 IL-17 receptor like molecules and uses thereof |
| 03/11/2004 | US20040048235 Methods and compositions for the selective modification of nucleic acids |
| 03/11/2004 | US20040047878 DNA vaccine against feline immunodeficiency virus |
| 03/11/2004 | US20040047840 Control agents |
| 03/11/2004 | US20040047836 A viral DNA construct, and virus encoded thereby, is provided having one or more tumour specific transcription factor binding sites in place of one or more wild type transcription factor binding sites operatively positioned in the promoter |
| 03/11/2004 | CA2496918A1 Chromatographic methods for adenovirus purification |
| 03/11/2004 | CA2496620A1 Non-human herpesviruses as vectors |
| 03/10/2004 | EP0762894B1 Method of inducing an immune response with a live venezuelan equine encephalitis virus expressing a heterologous immunogen |
| 03/10/2004 | CN1480534A Shuttle vector of repeatable adenovirus of targeting melanoma and adenovirus |
| 03/09/2004 | US6703486 Peripheral nervous system specific sodium channels |
| 03/09/2004 | US6703237 Recombinant adeno-associated virus (raav) vector comprising a heterologous sequence and heparin; for gene therapy |
| 03/09/2004 | US6703232 Contacting human embryo kidney 293 (hek 293) cells with at least two different reoviruses to infect; incubation to reassort; harvesting |
| 03/09/2004 | US6703231 gM-negative EHV-mutants |
| 03/04/2004 | WO2004018685A2 Active fusion proteins and method for the production thereof |
| 03/04/2004 | WO2004018630A2 Recombinant double-stranded rna phages and uses thereof |
| 03/04/2004 | WO2004018627A2 Methods for propagating adenovirus and virus produced thereby |
| 03/04/2004 | WO2004007538A3 Molecular antigen arrays using a virus like particle derived from the ap205 coat protein |
| 03/04/2004 | WO2003104476A3 Assay to detect replication competent viruses |
| 03/04/2004 | WO2003039225A3 Antigen arrays comprising rankl for treatment of bone disease |
| 03/04/2004 | US20040043490 Cells to be used in producing virus vector, process for producing the same, and process for producing virus vector with the use of the cells |
| 03/04/2004 | US20040043471 Production of chimeric human papillomavirus |
| 03/04/2004 | US20040043035 Recombinant newcastle disease virus nucleoprotein mutant as a marker vaccine |
| 03/04/2004 | DE10238846A1 Aktive Fusionsproteine und Verfahren zu ihrer Herstellung Active fusion proteins and methods for their preparation |
| 03/04/2004 | CA2536254A1 Recombinant double-stranded rna phages and uses thereof |
| 03/04/2004 | CA2495546A1 Methods for propagating adenovirus and virus produced thereby |
| 03/03/2004 | EP1394259A2 Recombinant infectious non-segmented negative strand RNA virus |
| 03/03/2004 | EP1394258A1 Non-human herpesviruses as vectors |
| 03/03/2004 | EP1394255A2 NANBV diagnostics and vaccines |